| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Image Interpretation, Computer-Assisted | 29 | 2018 | 237 | 7.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 33 | 2022 | 239 | 6.570 |
Why?
|
| Brain | 75 | 2022 | 2176 | 6.290 |
Why?
|
| Diffusion Tensor Imaging | 31 | 2022 | 211 | 5.540 |
Why?
|
| White Matter | 20 | 2022 | 174 | 4.270 |
Why?
|
| Magnetic Resonance Imaging | 53 | 2019 | 2223 | 4.150 |
Why?
|
| Iron | 13 | 2019 | 197 | 3.430 |
Why?
|
| Alzheimer Disease | 15 | 2022 | 565 | 3.050 |
Why?
|
| Image Enhancement | 24 | 2017 | 143 | 2.950 |
Why?
|
| Algorithms | 22 | 2017 | 1196 | 2.310 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 5 | 2019 | 189 | 2.070 |
Why?
|
| Image Processing, Computer-Assisted | 21 | 2018 | 689 | 1.990 |
Why?
|
| Axons | 12 | 2019 | 139 | 1.930 |
Why?
|
| Magnetic Resonance Spectroscopy | 37 | 2012 | 346 | 1.740 |
Why?
|
| Brain Mapping | 11 | 2018 | 532 | 1.610 |
Why?
|
| Nerve Fibers, Myelinated | 7 | 2014 | 49 | 1.500 |
Why?
|
| Body Water | 9 | 2016 | 35 | 1.500 |
Why?
|
| Water | 7 | 2018 | 230 | 1.420 |
Why?
|
| Models, Neurological | 7 | 2018 | 136 | 1.410 |
Why?
|
| Aging | 6 | 2018 | 911 | 1.210 |
Why?
|
| Sensitivity and Specificity | 20 | 2017 | 1753 | 1.090 |
Why?
|
| Diffusion | 17 | 2019 | 90 | 1.080 |
Why?
|
| Neuroimaging | 6 | 2019 | 122 | 1.040 |
Why?
|
| Anisotropy | 20 | 2020 | 105 | 1.020 |
Why?
|
| Reproducibility of Results | 21 | 2018 | 2077 | 1.020 |
Why?
|
| Epilepsy, Temporal Lobe | 6 | 2017 | 138 | 1.010 |
Why?
|
| Central Nervous System Stimulants | 2 | 2019 | 221 | 0.980 |
Why?
|
| Artifacts | 5 | 2014 | 125 | 0.930 |
Why?
|
| Cerebrovascular Circulation | 13 | 2017 | 296 | 0.880 |
Why?
|
| Humans | 97 | 2022 | 68618 | 0.860 |
Why?
|
| Male | 79 | 2020 | 37321 | 0.850 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2013 | 333 | 0.840 |
Why?
|
| Cognitive Dysfunction | 3 | 2013 | 176 | 0.790 |
Why?
|
| Ischemic Attack, Transient | 10 | 1998 | 167 | 0.730 |
Why?
|
| Brain Ischemia | 17 | 2017 | 665 | 0.710 |
Why?
|
| Female | 56 | 2019 | 38074 | 0.670 |
Why?
|
| Cerebral Infarction | 6 | 2017 | 103 | 0.660 |
Why?
|
| Spinal Cord | 2 | 2011 | 244 | 0.650 |
Why?
|
| Blood Volume | 3 | 2008 | 47 | 0.640 |
Why?
|
| Nerve Fibers | 3 | 2016 | 77 | 0.640 |
Why?
|
| Myelin Sheath | 2 | 2018 | 115 | 0.590 |
Why?
|
| Cerebral Cortex | 5 | 2017 | 415 | 0.560 |
Why?
|
| Adult | 38 | 2019 | 21403 | 0.560 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2016 | 100 | 0.550 |
Why?
|
| Corpus Callosum | 3 | 2014 | 29 | 0.540 |
Why?
|
| Amyloid beta-Peptides | 4 | 2005 | 191 | 0.540 |
Why?
|
| Models, Theoretical | 7 | 2019 | 384 | 0.540 |
Why?
|
| Neural Pathways | 6 | 2018 | 324 | 0.520 |
Why?
|
| Computer Simulation | 6 | 2018 | 706 | 0.510 |
Why?
|
| Animals | 51 | 2020 | 20881 | 0.500 |
Why?
|
| Data Interpretation, Statistical | 7 | 2017 | 329 | 0.490 |
Why?
|
| Middle Aged | 36 | 2022 | 21147 | 0.490 |
Why?
|
| Models, Statistical | 3 | 2015 | 448 | 0.490 |
Why?
|
| Demyelinating Diseases | 1 | 2014 | 57 | 0.470 |
Why?
|
| Magnetics | 4 | 2009 | 52 | 0.460 |
Why?
|
| Cocaine-Related Disorders | 1 | 2018 | 504 | 0.450 |
Why?
|
| Subtraction Technique | 2 | 2012 | 12 | 0.430 |
Why?
|
| Cerebrospinal Fluid | 1 | 2012 | 23 | 0.420 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 119 | 0.420 |
Why?
|
| Aged | 20 | 2022 | 14862 | 0.390 |
Why?
|
| Mice, Transgenic | 9 | 2020 | 1033 | 0.390 |
Why?
|
| Energy Metabolism | 8 | 1993 | 222 | 0.380 |
Why?
|
| Normal Distribution | 6 | 2015 | 46 | 0.370 |
Why?
|
| Monte Carlo Method | 1 | 2010 | 124 | 0.350 |
Why?
|
| Hyperglycemia | 4 | 1998 | 158 | 0.350 |
Why?
|
| Central Nervous System | 1 | 2010 | 107 | 0.350 |
Why?
|
| Stroke | 4 | 2018 | 2163 | 0.340 |
Why?
|
| Frontal Lobe | 2 | 2011 | 156 | 0.340 |
Why?
|
| Echo-Planar Imaging | 2 | 2014 | 17 | 0.340 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2009 | 5 | 0.330 |
Why?
|
| Models, Biological | 2 | 2010 | 981 | 0.330 |
Why?
|
| Gray Matter | 5 | 2018 | 57 | 0.320 |
Why?
|
| Aged, 80 and over | 6 | 2022 | 4848 | 0.320 |
Why?
|
| Temporal Lobe | 4 | 2017 | 125 | 0.310 |
Why?
|
| Mice | 13 | 2018 | 8474 | 0.310 |
Why?
|
| Contrast Media | 3 | 2008 | 595 | 0.310 |
Why?
|
| Biomarkers | 3 | 2022 | 1593 | 0.300 |
Why?
|
| Multiple Sclerosis | 3 | 2017 | 132 | 0.300 |
Why?
|
| Phosphates | 13 | 1993 | 72 | 0.290 |
Why?
|
| Adolescent | 7 | 2019 | 8912 | 0.290 |
Why?
|
| Plaque, Amyloid | 2 | 2018 | 31 | 0.290 |
Why?
|
| Phantoms, Imaging | 6 | 2006 | 189 | 0.280 |
Why?
|
| Brain Diseases | 2 | 2005 | 78 | 0.270 |
Why?
|
| Child | 6 | 2019 | 6405 | 0.270 |
Why?
|
| Substantia Nigra | 3 | 1995 | 102 | 0.270 |
Why?
|
| Blood Volume Determination | 1 | 2005 | 3 | 0.270 |
Why?
|
| Aphasia | 2 | 2018 | 119 | 0.270 |
Why?
|
| Rats | 22 | 2015 | 5300 | 0.270 |
Why?
|
| Disease Models, Animal | 8 | 2018 | 2550 | 0.250 |
Why?
|
| Biopolymers | 1 | 2004 | 21 | 0.240 |
Why?
|
| Nonlinear Dynamics | 1 | 2004 | 55 | 0.240 |
Why?
|
| Statistical Distributions | 3 | 2015 | 8 | 0.240 |
Why?
|
| Magnetic Fields | 2 | 2016 | 21 | 0.240 |
Why?
|
| Ferric Compounds | 1 | 2004 | 45 | 0.240 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2015 | 93 | 0.230 |
Why?
|
| Pattern Recognition, Automated | 2 | 2014 | 70 | 0.220 |
Why?
|
| Prefrontal Cortex | 1 | 2008 | 640 | 0.220 |
Why?
|
| Migraine Disorders | 6 | 1992 | 66 | 0.210 |
Why?
|
| Hippocampus | 3 | 2016 | 471 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 2791 | 0.210 |
Why?
|
| Neurodegenerative Diseases | 1 | 2003 | 102 | 0.200 |
Why?
|
| Magnesium | 5 | 1993 | 110 | 0.200 |
Why?
|
| Statistics, Nonparametric | 2 | 2014 | 306 | 0.190 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 782 | 0.190 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 371 | 0.180 |
Why?
|
| Presenilin-1 | 3 | 2004 | 28 | 0.180 |
Why?
|
| Pyramidal Tracts | 2 | 2017 | 45 | 0.180 |
Why?
|
| Hydrogen-Ion Concentration | 15 | 1995 | 618 | 0.180 |
Why?
|
| Age Factors | 3 | 2013 | 1864 | 0.170 |
Why?
|
| Brain Injuries | 2 | 2015 | 268 | 0.170 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2004 | 115 | 0.170 |
Why?
|
| Bevacizumab | 1 | 2019 | 34 | 0.170 |
Why?
|
| Brain Chemistry | 3 | 1994 | 173 | 0.160 |
Why?
|
| Occipital Lobe | 2 | 2017 | 18 | 0.160 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 66 | 0.160 |
Why?
|
| Statistics as Topic | 2 | 2012 | 219 | 0.160 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 1999 | 85 | 0.160 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2018 | 13 | 0.160 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1999 | 181 | 0.150 |
Why?
|
| Phosphocreatine | 9 | 1993 | 20 | 0.150 |
Why?
|
| Language | 1 | 2018 | 120 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2012 | 1342 | 0.150 |
Why?
|
| Phosphorus | 10 | 1993 | 64 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2002 | 659 | 0.140 |
Why?
|
| Movement Disorders | 1 | 2017 | 58 | 0.140 |
Why?
|
| Reference Values | 6 | 2018 | 579 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 446 | 0.140 |
Why?
|
| Glioblastoma | 1 | 2019 | 219 | 0.140 |
Why?
|
| Adenosine Triphosphate | 8 | 1993 | 314 | 0.130 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2016 | 44 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2022 | 2358 | 0.130 |
Why?
|
| Case-Control Studies | 3 | 2014 | 1553 | 0.130 |
Why?
|
| Membrane Proteins | 3 | 2004 | 617 | 0.130 |
Why?
|
| Arterioles | 1 | 2015 | 40 | 0.130 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 1174 | 0.130 |
Why?
|
| Blood-Brain Barrier | 3 | 1995 | 99 | 0.130 |
Why?
|
| Retrospective Studies | 4 | 2016 | 7277 | 0.130 |
Why?
|
| Parkinson Disease | 2 | 1995 | 272 | 0.130 |
Why?
|
| Amygdala | 1 | 2016 | 159 | 0.120 |
Why?
|
| Young Adult | 4 | 2017 | 5717 | 0.120 |
Why?
|
| Blood Flow Velocity | 4 | 2015 | 172 | 0.120 |
Why?
|
| Sensorimotor Cortex | 1 | 2015 | 18 | 0.120 |
Why?
|
| Brain Edema | 1 | 1995 | 50 | 0.120 |
Why?
|
| Regional Blood Flow | 2 | 2008 | 168 | 0.120 |
Why?
|
| Cuprizone | 1 | 2014 | 3 | 0.120 |
Why?
|
| Epilepsy, Generalized | 1 | 2014 | 15 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2008 | 2083 | 0.120 |
Why?
|
| Disease Progression | 2 | 2018 | 1038 | 0.120 |
Why?
|
| Tissue Distribution | 2 | 2012 | 282 | 0.120 |
Why?
|
| Multimodal Imaging | 1 | 2014 | 62 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2019 | 3705 | 0.110 |
Why?
|
| Time Factors | 10 | 2015 | 4655 | 0.110 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2013 | 12 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2017 | 342 | 0.110 |
Why?
|
| Semantics | 1 | 2013 | 37 | 0.110 |
Why?
|
| Radiology | 1 | 2015 | 97 | 0.110 |
Why?
|
| Radiation Dosage | 1 | 2016 | 419 | 0.110 |
Why?
|
| Down Syndrome | 1 | 2014 | 120 | 0.110 |
Why?
|
| Molecular Structure | 1 | 2014 | 397 | 0.110 |
Why?
|
| Electromagnetic Fields | 1 | 1993 | 66 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 214 | 0.110 |
Why?
|
| Radiation Protection | 1 | 1993 | 71 | 0.100 |
Why?
|
| Connectome | 1 | 2013 | 92 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2015 | 622 | 0.100 |
Why?
|
| Feasibility Studies | 3 | 2004 | 652 | 0.100 |
Why?
|
| Fever | 2 | 1989 | 96 | 0.100 |
Why?
|
| Neurons | 4 | 2017 | 881 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 517 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2015 | 310 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1040 | 0.090 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 86 | 0.090 |
Why?
|
| Epilepsy | 1 | 1995 | 336 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 149 | 0.090 |
Why?
|
| Cell Membrane Permeability | 1 | 2010 | 59 | 0.090 |
Why?
|
| Microcirculation | 2 | 2015 | 77 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 217 | 0.090 |
Why?
|
| Acid-Base Equilibrium | 1 | 1990 | 10 | 0.090 |
Why?
|
| Muscles | 2 | 1992 | 158 | 0.090 |
Why?
|
| Rubidium | 1 | 1989 | 2 | 0.090 |
Why?
|
| Intracellular Membranes | 2 | 1990 | 86 | 0.090 |
Why?
|
| Cats | 11 | 1992 | 292 | 0.080 |
Why?
|
| Erythrocytes | 1 | 1989 | 137 | 0.080 |
Why?
|
| Comorbidity | 1 | 2013 | 1426 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2015 | 596 | 0.080 |
Why?
|
| Perfusion | 3 | 1999 | 131 | 0.080 |
Why?
|
| Hydrogen | 1 | 1988 | 35 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 1988 | 72 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 438 | 0.080 |
Why?
|
| Gadolinium DTPA | 1 | 2008 | 48 | 0.080 |
Why?
|
| Porphyrins | 1 | 1987 | 15 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1851 | 0.070 |
Why?
|
| Least-Squares Analysis | 1 | 2007 | 35 | 0.070 |
Why?
|
| Linear Models | 1 | 2008 | 521 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 1465 | 0.070 |
Why?
|
| Necrosis | 3 | 2018 | 239 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2013 | 551 | 0.070 |
Why?
|
| Glioma | 1 | 2007 | 140 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 183 | 0.070 |
Why?
|
| Acidosis | 4 | 1992 | 31 | 0.070 |
Why?
|
| Equipment Design | 2 | 2001 | 500 | 0.070 |
Why?
|
| Blood Glucose | 3 | 1997 | 631 | 0.070 |
Why?
|
| Datasets as Topic | 2 | 2015 | 53 | 0.060 |
Why?
|
| 3,3'-Diaminobenzidine | 1 | 2005 | 2 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2008 | 705 | 0.060 |
Why?
|
| Putamen | 1 | 2005 | 35 | 0.060 |
Why?
|
| Caudate Nucleus | 1 | 2005 | 56 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 786 | 0.060 |
Why?
|
| Functional Laterality | 2 | 2017 | 240 | 0.060 |
Why?
|
| Tissue Fixation | 1 | 2005 | 58 | 0.060 |
Why?
|
| Heart Arrest | 2 | 1997 | 113 | 0.060 |
Why?
|
| Movement | 2 | 2003 | 179 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2003 | 63 | 0.060 |
Why?
|
| Gyrus Cinguli | 1 | 2004 | 113 | 0.050 |
Why?
|
| Exercise | 1 | 1989 | 658 | 0.050 |
Why?
|
| Deuterium | 1 | 2003 | 10 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 181 | 0.050 |
Why?
|
| Protons | 1 | 2003 | 57 | 0.050 |
Why?
|
| 1-Carboxyglutamic Acid | 1 | 1982 | 1 | 0.050 |
Why?
|
| Glutamates | 1 | 1982 | 41 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2013 | 2455 | 0.050 |
Why?
|
| Hypothermia, Induced | 2 | 1994 | 93 | 0.050 |
Why?
|
| HIV-1 | 1 | 2002 | 177 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2002 | 206 | 0.050 |
Why?
|
| Bioprosthesis | 1 | 1982 | 101 | 0.050 |
Why?
|
| Rats, Inbred F344 | 4 | 1994 | 104 | 0.050 |
Why?
|
| Cell Count | 2 | 2018 | 248 | 0.050 |
Why?
|
| Calcinosis | 1 | 1982 | 241 | 0.040 |
Why?
|
| Heart Valve Prosthesis | 1 | 1982 | 222 | 0.040 |
Why?
|
| Rats, Wistar | 4 | 2011 | 371 | 0.040 |
Why?
|
| Neurofibrillary Tangles | 1 | 2018 | 8 | 0.040 |
Why?
|
| Hematoporphyrins | 2 | 1991 | 4 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 3259 | 0.040 |
Why?
|
| Chlorofluorocarbons, Methane | 4 | 1992 | 4 | 0.040 |
Why?
|
| Mutation | 1 | 2004 | 1213 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2019 | 163 | 0.040 |
Why?
|
| Photochemotherapy | 2 | 1991 | 59 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 1999 | 219 | 0.040 |
Why?
|
| Support Vector Machine | 1 | 2017 | 15 | 0.040 |
Why?
|
| Partial Pressure | 1 | 1997 | 19 | 0.040 |
Why?
|
| Speech Therapy | 1 | 2017 | 19 | 0.040 |
Why?
|
| Infant | 2 | 2014 | 2891 | 0.040 |
Why?
|
| Vibrissae | 1 | 2017 | 6 | 0.040 |
Why?
|
| Intracranial Thrombosis | 1 | 2017 | 14 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 1997 | 78 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2014 | 3187 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 2017 | 67 | 0.040 |
Why?
|
| Oxygen | 2 | 1997 | 386 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2017 | 114 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 7029 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 238 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2017 | 112 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 78 | 0.030 |
Why?
|
| Machine Learning | 1 | 2017 | 170 | 0.030 |
Why?
|
| Depression | 1 | 2002 | 943 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2018 | 1330 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2017 | 307 | 0.030 |
Why?
|
| Limbic System | 1 | 2016 | 106 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 2 | 1993 | 182 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 737 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2017 | 298 | 0.030 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 1995 | 40 | 0.030 |
Why?
|
| Licensure | 1 | 2015 | 18 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 53 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2014 | 134 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 337 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 275 | 0.030 |
Why?
|
| HIV Infections | 1 | 2002 | 791 | 0.030 |
Why?
|
| Extracellular Space | 1 | 1995 | 121 | 0.030 |
Why?
|
| Mentors | 1 | 2015 | 81 | 0.030 |
Why?
|
| Synapses | 1 | 2017 | 222 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 274 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2015 | 203 | 0.030 |
Why?
|
| Logistic Models | 1 | 1998 | 1420 | 0.030 |
Why?
|
| Career Choice | 1 | 2015 | 98 | 0.030 |
Why?
|
| Problem-Based Learning | 1 | 2015 | 72 | 0.030 |
Why?
|
| External Capsule | 1 | 2013 | 3 | 0.030 |
Why?
|
| Alcoholism | 1 | 2002 | 1109 | 0.030 |
Why?
|
| Internal Capsule | 1 | 2013 | 7 | 0.030 |
Why?
|
| Nerve Net | 1 | 2016 | 181 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 188 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 1993 | 24 | 0.030 |
Why?
|
| Cerebral Arterial Diseases | 1 | 1993 | 28 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 240 | 0.030 |
Why?
|
| Nuclear Medicine Department, Hospital | 1 | 1993 | 1 | 0.030 |
Why?
|
| Steel | 1 | 1993 | 1 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 1993 | 25 | 0.030 |
Why?
|
| Indicator Dilution Techniques | 2 | 1991 | 8 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1993 | 134 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1993 | 193 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 1995 | 396 | 0.030 |
Why?
|
| Carbon | 1 | 1993 | 122 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1992 | 765 | 0.030 |
Why?
|
| Surface Properties | 1 | 1993 | 363 | 0.030 |
Why?
|
| Brain Death | 1 | 1992 | 34 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2013 | 418 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1997 | 1451 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 144 | 0.020 |
Why?
|
| Curriculum | 1 | 2015 | 575 | 0.020 |
Why?
|
| Resuscitation | 1 | 1991 | 77 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2011 | 113 | 0.020 |
Why?
|
| Alkalosis | 1 | 1990 | 5 | 0.020 |
Why?
|
| Dementia, Multi-Infarct | 1 | 1989 | 2 | 0.020 |
Why?
|
| Phospholipids | 1 | 1990 | 108 | 0.020 |
Why?
|
| Edetic Acid | 1 | 1989 | 29 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1989 | 69 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 1991 | 211 | 0.020 |
Why?
|
| Peroneal Nerve | 1 | 1989 | 6 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 1989 | 53 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1989 | 160 | 0.020 |
Why?
|
| Biological Transport | 1 | 1989 | 210 | 0.020 |
Why?
|
| Body Temperature | 1 | 1989 | 116 | 0.020 |
Why?
|
| Reperfusion | 1 | 1988 | 78 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 1989 | 218 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 630 | 0.020 |
Why?
|
| South Carolina | 1 | 2015 | 2752 | 0.020 |
Why?
|
| Models, Structural | 1 | 1987 | 22 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2011 | 506 | 0.020 |
Why?
|
| Heart Failure | 1 | 1995 | 1180 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 1985 | 102 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1986 | 358 | 0.010 |
Why?
|
| Hypoxia, Brain | 1 | 1984 | 16 | 0.010 |
Why?
|
| Fourier Analysis | 2 | 1994 | 31 | 0.010 |
Why?
|
| Cerebral Arteries | 2 | 1994 | 50 | 0.010 |
Why?
|
| Species Specificity | 1 | 2003 | 303 | 0.010 |
Why?
|
| Phosphorus Isotopes | 3 | 1989 | 9 | 0.010 |
Why?
|
| United States | 1 | 2015 | 7367 | 0.010 |
Why?
|
| Fluorine | 2 | 1992 | 3 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1982 | 123 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 532 | 0.010 |
Why?
|
| Myocardium | 1 | 1986 | 1204 | 0.010 |
Why?
|
| Spectrum Analysis | 2 | 1986 | 81 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1994 | 94 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 1994 | 25 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1993 | 41 | 0.010 |
Why?
|
| Acute Disease | 1 | 1995 | 658 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1993 | 149 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 1993 | 85 | 0.010 |
Why?
|
| Neutrophils | 1 | 1994 | 204 | 0.010 |
Why?
|
| Hypercapnia | 1 | 1992 | 17 | 0.010 |
Why?
|
| Dihematoporphyrin Ether | 1 | 1991 | 3 | 0.010 |
Why?
|
| Prosencephalon | 1 | 1991 | 38 | 0.010 |
Why?
|
| Tidal Volume | 1 | 1991 | 17 | 0.010 |
Why?
|
| Dementia | 1 | 1992 | 158 | 0.010 |
Why?
|
| Organophosphates | 1 | 1989 | 7 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1989 | 13 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1989 | 29 | 0.010 |
Why?
|
| Solubility | 1 | 1990 | 134 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 1989 | 59 | 0.010 |
Why?
|
| Fluorine Radioisotopes | 1 | 1989 | 13 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1989 | 133 | 0.000 |
Why?
|
| 5-Hydroxytryptophan | 1 | 1985 | 4 | 0.000 |
Why?
|
| Nucleotides, Cyclic | 1 | 1985 | 5 | 0.000 |
Why?
|
| Catecholamines | 1 | 1985 | 73 | 0.000 |
Why?
|